Kasper Jürgen, Köpke Sascha, Mühlhauser Ingrid, Heesen Christoph
Unit of Health Sciences and Education, University of Hamburg, Martin Luther King Platz 6, 20146 Hamburg, Germany.
Patient Educ Couns. 2006 Jul;62(1):56-63. doi: 10.1016/j.pec.2005.06.002. Epub 2005 Aug 10.
This study analysis the comprehension and emotional responses of people suffering from multiple sclerosis when provided with an evidence-based information module. It is a core module of a comprehensive decision aid about immunotherapy. The core module is designed to enable patients to process scientific uncertainty without adverse effects. It considers existing standards for risk communication and presentation of data.
Using a mailing approach we investigated 169 patients with differing courses of disease in a before-after design. Items addressed the competence in processing relative and absolute risk information and patients' emotional response to the tool, comprising grade of familiarity with the information, understanding, relevance, emotional arousal, and certainty.
Overall, numeracy improved (p < 0.001), although 99 of 169 patients did not complete the numeracy task correctly. Understanding depended on the relevance related to the course of disease. A moderate level of uncertainty was induced. No adverse emotional responses could be shown, neither in those who did comprehend the information, nor in those who did not develop numeracy skills.
In conclusion, the tool supports people suffering from multiple sclerosis to process evidence-based medical information and scientific uncertainty without burdening them emotionally.
This study is an example for the documentation of an important step in the development process of a complex intervention.
本研究分析了多发性硬化症患者在获得基于证据的信息模块时的理解情况和情绪反应。该信息模块是免疫治疗综合决策辅助工具的核心模块。核心模块旨在使患者能够处理科学上的不确定性而不产生不利影响。它考虑了风险沟通和数据呈现的现有标准。
我们采用邮寄方式,以前后对照设计对169例病程不同的患者进行了调查。调查项目涉及处理相对和绝对风险信息的能力以及患者对该工具的情绪反应,包括对信息的熟悉程度、理解程度、相关性、情绪唤起和确定性。
总体而言,计算能力有所提高(p < 0.001),尽管169例患者中有99例未正确完成计算任务。理解程度取决于与病程的相关性。引发了适度的不确定性。无论是理解了信息的患者,还是未掌握计算技能的患者,均未表现出不良情绪反应。
总之,该工具支持多发性硬化症患者处理基于证据的医学信息和科学上的不确定性,而不会给他们带来情感负担。
本研究为例证,记录了复杂干预措施开发过程中的重要一步。